GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » EV-to-FCF

Cresco Labs (XCNQ:CL) EV-to-FCF : 12.26 (As of Dec. 13, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cresco Labs's Enterprise Value is C$1,239.9 Mil. Cresco Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was C$101.2 Mil. Therefore, Cresco Labs's EV-to-FCF for today is 12.26.

The historical rank and industry rank for Cresco Labs's EV-to-FCF or its related term are showing as below:

XCNQ:CL' s EV-to-FCF Range Over the Past 10 Years
Min: -1485.39   Med: -23.51   Max: 2477.93
Current: 12.63

During the past 13 years, the highest EV-to-FCF of Cresco Labs was 2477.93. The lowest was -1485.39. And the median was -23.51.

XCNQ:CL's EV-to-FCF is ranked better than
75.5% of 551 companies
in the Drug Manufacturers industry
Industry Median: 25.85 vs XCNQ:CL: 12.63

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), Cresco Labs's stock price is C$1.38. Cresco Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.268. Therefore, Cresco Labs's PE Ratio (TTM) for today is At Loss.


Cresco Labs EV-to-FCF Historical Data

The historical data trend for Cresco Labs's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs EV-to-FCF Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.85 -26.04 -28.45 -15.65 1,403.24

Cresco Labs Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,557.95 1,403.24 24.50 17.53 13.70

Competitive Comparison of Cresco Labs's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Cresco Labs's EV-to-FCF falls into.



Cresco Labs EV-to-FCF Calculation

Cresco Labs's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1239.938/101.172
=12.26

Cresco Labs's current Enterprise Value is C$1,239.9 Mil.
Cresco Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$101.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs  (XCNQ:CL) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Cresco Labs's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.38/-0.268
=At Loss

Cresco Labs's share price for today is C$1.38.
Cresco Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.268.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Cresco Labs EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Cresco Labs's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs Business Description

Traded in Other Exchanges
Address
400 West Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.